Skip to main content

Table 2 Odds ratios (ORs) and 95% confidence intervals (CIs) for dyslipidemia in relation to height for total subjects, stratified by BMI status

From: Height correlates with dyslipidemia in non-overweight middle-aged Japanese men

  Height quartiles p for trend 1 SD increment of height (5.7 cm)
Q1 (low) Q2 Q3 Q4 (high)
Total subjects
 No. of paticipants 750 753 752 761   
 No. of cases (%) 426 (56.8) 392 (52.1) 395 (52.5) 375 (49.3)   
 Age-adjusted ORs 1.00 0.86 (0.70, 1.05) 0.89 (0.73, 1.09) 0.80 (0.65, 0.98) 0.055 0.95 (0.88, 1.02)
 Multivariable ORs 1.00 0.84 (0.68, 1.04) 0.86 (0.69, 1.07) 0.78 (0.62, 0.97) 0.040 0.94 (0.87, 1.01)
BMI < 25 kg/m2
 No. of paticipants 485 489 483 495   
 No. of cases (%) 237 (48.9) 221 (45.2) 199 (41.2) 192 (38.8)   
 Age-adjusted ORs 1.00 0.91 (0.71, 1.17) 0.79 (0.61, 1.02) 0.74 (0.57, 0.95) 0.011 0.91 (0.83, 0.99)
 Multivariable ORs 1.00 0.86 (0.66, 1.12) 0.75 (0.57, 0.98) 0.72 (0.55, 0.95) 0.011 0.90 (0.82, 0.99)
BMI ≥ 25 kg/m2
 No. of paticipants 265 264 269 266   
 No. of cases (%) 189 (71.3) 171 (64.8) 196 (72.9) 183 (68.8)   
 Age-adjusted ORs 1.00 0.75 (0.52, 1.08) 1.10 (0.75, 1.61) 0.91 (0.62, 1.32) 0.865 1.02 (0.89, 1.16)
 Multivariable ORs 1.00 0.77 (0.53, 1.12) 1.11 (0.75, 1.63) 0.91 (0.62, 1.34) 0.860 1.02 (0.89, 1.17)
  1. Dyslipidemia is defined as TG ≥ 150 mg/dL and/or LDL-choresterol ≥ 140 mg/dL, and/or HDL-cholesterol < 40 mg/dL, and/or lipid lowering medication use. Multivariable ORs adjusted further for age, systolic blood pressure, antihypertensive medication use, body mass index, smoking status, alcohol consumption, blood sugar, glucose lowering medication use, and serum creatinine. Height quartiles are <166.7 cm for Q1, 166.7–170.3 cm for Q2, 170.4–174.2 cm for Q3, >174.2 cm for Q4